Glycaemic outcomes in adults with type 1 diabetes transitioning towards advanced automated insulin delivery systems - a real-world analysis at a Swiss tertiary centre

被引:1
|
作者
Lehmann, Vera [1 ]
Noti, Franco [1 ]
Laimer, Markus [1 ]
Stettler, Christoph [1 ]
Zuger, Thomas [1 ,2 ]
机构
[1] Univ Bern, Bern Univ Hosp, Inselspital, Dept Diabet Endocrinol Nutr Med & Metab, CH-3010 Bern, Switzerland
[2] Kantonsspital Olten, Dept Diabet Endocrinol & Metab Dis, Olten, Switzerland
关键词
HYBRID CLOSED-LOOP;
D O I
10.57187/s.3501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIMS OF THE STUDY: To assess glucose levels in adults with diabetes at a Swiss tertiary hospital when transitioning from insulin delivery with a sensor-augmented pump with (predictive) low-glucose suspend ([P]LGS) to a hybrid-closed loop (HCL) and from a HCL to an advanced hybrid-closed loop (AHCL). METHODS: Continuous glucose monitoring data for 44 adults with type 1 diabetes transitioning from (P)LGS to hybrid-closed loop and from hybrid-closed loop to advanced hybrid-closed loop were analysed, including the percentage of time spent within, below, and above glucose ranges. In addition, a subgroup analysis (n = 14) of individuals undergoing both transitions was performed. RESULTS: The transition from a (P)LGS to a hybrid-closed loop was associated with increased time in range (6.6% [2.6%-12.7%], p <0.001) and decreased time above range (5.6% [2.3%-12.7%], p <0.001). The transition from a hybrid-closed loop to an advanced hybrid-closed loop was associated with increased time in range (1.6% [-0.5%-4.5%], p = 0.046) and decreased time above range (1.5% [-1.8%-5.6%], p = 0.050). Both transitions did not change the time below range. In the subgroup analysis ([P]LGS. HCL. AHCL), the time in range increased from 69.4% (50.3%-79.2%) to 76.5% (65.3%-81.3%) and 78.7% (69.7%-85.8%), respectively (p <0.001). CONCLUSIONS: Glucose levels significantly improved when transitioning from a (P)LGS to a hybrid-closed loop. Glucose levels improved further when switching from a hybrid-closed loop to an advanced hybrid-closed loop. However, the added benefit of an advanced hybrid-closed loop was comparably smaller. This pattern was also reflected in the subgroup analysis.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit
    Heald, A. H.
    Livingston, M.
    Fryer, A.
    Moreno, G. Y. C.
    Malipatil, N.
    Gadsby, R.
    Ollier, W.
    Lunt, M.
    Stedman, M.
    Young, R. J.
    DIABETIC MEDICINE, 2018, 35 (01) : 63 - 71
  • [22] Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes
    Piona, Claudia
    Passanisi, Stefano
    Bombaci, Bruno
    Marigliano, Marco
    Lombardo, Fortunato
    Mancioppi, Valentina
    Morandi, Anita
    Maffeis, Claudio
    Salzano, Giuseppina
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4767 - 4771
  • [23] Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes
    Forlenza, Gregory P.
    DeSalvo, Daniel J.
    Aleppo, Grazia
    Wilmot, Emma G.
    Berget, Cari
    Huyett, Lauren M.
    Hadjiyianni, Irene
    Mendez, Jose J.
    Conroy, Lindsey R.
    Ly, Trang T.
    Sherr, Jennifer L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (08) : 514 - 525
  • [24] REAL WORLD EXPERIENCE OF LONG-TERM GLYCAEMIC CONTROL WITH INSULIN PUMP AMONG ADULTS WITH TYPE 1 DIABETES
    Jarvela, A.
    Metso, S.
    Hannula, P.
    Lahtela, J. T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A126 - A126
  • [25] Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review
    Knoll, Christine
    Peacock, Sofia
    Waldchen, Mandy
    Cooper, Drew
    Aulakh, Simran Kaur
    Raile, Klemens
    Hussain, Sufyan
    Braune, Katarina
    DIABETIC MEDICINE, 2022, 39 (05)
  • [26] Real-World Analysis of Therapeutic Outcome in Type 1 Diabetes Mellitus at a Tertiary Care Center
    Kietaibl, Antonia
    Riedl, Michaela
    Bozkurt, Latife
    DIABETES & METABOLISM JOURNAL, 2022, 46 (01) : 149 - 153
  • [27] Real-World Glycemic Outcomes of &gt;5,900 Adults with Type 1 Diabetes Using the Omnipod 5 Automated Insulin Delivery (AID) System with Cloud-Based Data Management
    Lal, Rayhan
    Aleppo, Grazia
    Huyett, Lauren M.
    Snow, Kenneth
    Mendez, Jose J.
    Hadjiyianni, Irene
    Ly, Trang T.
    DIABETES, 2023, 72
  • [28] Closed-Loop Insulin Therapy in Older Adults with Type 1 Diabetes: Real-World Data
    Toschi, Elena
    Atakov-Castillo, Astrid
    Slyne, Christine
    Munshi, Medha
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (02) : 140 - 142
  • [29] GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study
    Holmager, Pernille
    Christensen, Merete Bechmann
    Norgaard, Kirsten
    Schmidt, Signe
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
  • [30] GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study
    Holmager, Pernille
    Christensen, Merete Bechmann
    Norgaard, Kirsten
    Schmidt, Signe
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2025, 19 (02): : 286 - 291